GC Wellbeing is the leading company in the nutritional injection market in Korea, led by placenta injection 'LAENNEC inj.', and is now agressively expanding its scope to the medical aesthetic sector as well. GC Wellbeing, which will start its aesthetic business for the first time under the GC group, will launch its aesthetic brand 'GCELLE' in 2026 this year, ahead of the release of 1) hyaluronic acid fillers that are guaranteed safety and stability by obtaining CE certification, and 2) skin boosters derived from human collagen. Last year, it acquired INIBIO, a botulinum toxin manufacturing and distributing company. GC Wellbeing plans to successfully build full line-up of all aesthetic products including Botulinium toxin, fillers and skin booster to actively target the global aesthetic market.